Publications and patents 2022

2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010

 

  1. Calcoen B, Callebaut K, Vandenbulcke A, Callewaert N, Bossuyt X, van Weyenbergh J, Maes P, Imbrechts M, Vercruysse T, Thibaut HJ, Zapf D, Dieckmann K, Vanhoorelbeke K, Geukens N, de Meyer S, Maes W. Real-world monitoring of BNT162b2 vaccine-induced SARS-CoV-2 B and T cell immunity in naive healthcare workers: a prosprective single center study. medRxiv doi: 10.1101/2022.01.17.22269081 (2022)
  2. Dolscheid-Pommerich R, Bartok E, Renn M, Kümmerer BM, Schulte B, Schmithausen RM, Stoffel-Wagner B, Streeck H, Saschenbrecker S, Steinhagen K, Hartmann G. Correlation between a quantitative anti-SARS-CoV-2 IgG ELISA and neutralization activity. J Med Virol 94(1):388-392 (2022).
  3. Egger M, Penziner S, Dichtl K, Gornicec M, Kriegl L, Krause R, Khong E, Mehta S, Vargas M, Gianella S, Porrachia M, Jenks JD, Venkataraman I, Hoenigl M. Performance of the EUROIMMUN Aspergillus antigen ELISA for the diagnosis of invasive pulmonary aspergillosis in bronchoalveolar lavage fluid. J Clin Microbiol doi: 10.1128/jcm.00215-22 (2022).
  4. Hayashi JY, Simizo A, Miyamoto JG, Costa LVS, Souza OF, Chiarelli T, Bacarov NBS, Hidalgo R, Garcia LD, Soane MM, Braconi CT, Maricato JT, Janini LM, Salomão R, Popi AF, Glezer I, Bonetti T, Tashima AK. Humoral and cellular responses to vaccination with homologous CoronaVac or ChAdOx1 and heterologous third dose with BNT162b2. J Infect doi: 10.1016/j.jinf.2022.02.026 (2022).
  5. Henry BM, Benoit SW, Lippi G, Sabalza M, Venkataraman I, Geisler D, Freeman MC, Rapsinski GJ, Wheeler SE. False-positive rates in pediatric SARS-CoV-2 serology testing. Am J Clin Pathol 157(2):314-316 (2022).
  6. Krzemień P, Kasperczyk S, Banach M, Kasperczyk A, Dobrakowski M, Tomasik T, Windak A, Mastej M, Catapano A, Ray KK, Mikhailidis DP, Toth PP, Howard G, Lip GY, Tomaszewski M, Charchar FJ, Sattar N, Williams B, MacDonald TM, Penson PE, Jóźwiak JJ. Relationship Between Anti-DFS70 Autoantibodies and Oxidative Stress. Biomark Insights 17:11772719211066791 (2022).
  7. Krzemień P, Kasperczyk S, Banach M, Kasperczyk A, Dobrakowski M, Tomasik T, Windak A, Mastej M, Catapano A, Ray KK, Mikhailidis DP, Toth PP, Howard G, Lip GYH, Tomaszewski M, Charchar FJ, Sattar N, Williams B, MacDonald TM, Penson PE, Jóźwiak JJ; LIPIDOGRAM2015 Investigators.Analysis of the impact of sex and age on the variation in the prevalence of antinuclear autoantibodies in Polish population: a nationwide observational, cross-sectional study. Rheumatol Int 4 (2021).
  8. Lanz TV, Brewer RC, Ho PP, Moon JS, Jude KM, Fernandez D, Fernandes RA, Gomez AM, Nadj GS, Bartley CM, Schubert RD, Hawes IA, Vazquez SE, Iyer M, Zuchero JB, Teegen B, Dunn JE, Lock CB, Kipp LB, Cotham VC, Ueberheide BM, Aftab BT, Anderson MS, DeRisi JL, Wilson MR, Bashford-Rogers RJM, Platten M, Garcia KC, Steinman L, Robinson WH. Clonally expanded B cells in multiple sclerosis bind EBV EBNA1 and GlialCAM. Nature 603(7900):321-327 (2022).
  9. Markewitz R, Juhl D, Pauli D, Görg S, Junker R, Rupp J, Engel S, Steinhagen K, Herbst V, Zapf D, Krüger C, Brockmann C, Leypoldt F, Dargvainiene J, Schomburg B, Sharifzadeh S, Nejad LS, Wandinger KP, Ziemann M. Kinetics of the antibody response to boostering with three differential vaccines against SARS-CoV-2. Front Immunol 13:811020 (2022).
  10. Sabalza M, Heckler I, Elhage A, Venkataraman, I, Henry B. COVID-19: testing landscape post-infection, -vaccination, and future perspectives. Viral Immunol 35(1):5-14 (2022).
  11. Steiner J, Stoecker W, Teegen B, Dobrowolny H, Meyer-Lotz G, Borucki K, Guest PC, Bernstein HG. Testing for thyroid peroxidase and antineuronal antibodies in depression and schizophrenia. Methods Mol Biol 2343:203-213 (2022).
  1. Dieckmann K, Grage-Griebenow E, Saschenbrecker S, Kubala V, Valová P, Lochman I. Novel interferon-gamma release assay for the quantitative determination of SARS-CoV-2-specific T-cell reactivity. 32nd European Congress of Clinical Microbiolgoy and Infectious Diseases (ECCMID), Lisbon, Portugal (2022).
  2. Hohensee, S, Langer N, Saschenbrecker S, Ott N, Meyer W, Scheper T, Steinhagen K. Determination of vaccine-induced binding and neutralizing antibodies against SARS-CoV-2 using standardized assays. 32nd European Congress of Clinical Microbiolgoy and Infectious Diseases (ECCMID), Lisbon, Portugal (2022).
  3. Van Beers J, Damoiseaux J, Jobsen M, Bestmann Y, Dähnrich C, Kühnl A, Schlumberger W. Routine application of PR3- and MPO-ANCA chemiluminescence immunoassays demonstrates enhanced detection rates. 20th International Vasculitis and ANCA Workshop, Dublin, Ireland (2022).
  1. Dieckmann K. The development of innovative test systems at EUROIMMUN – from the idea to approval. CORVOS Online Symposium on the Development and Application of Diagnostics and Antibiotics, virtuelles Symposium (2022).
  2. Dieckmann K. T cells: Important pillar of immune protection against SARS-CoV-2. INER Chemical Conferences in Mexico, Webinar (2022).
  1. Gerlach S, Krauth J, Marzahl C, Krause C, Danckwardt M, Hahn M, Voigt J. Verfahren zum Detektieren einer Bindung von Antikörpern einer Patientenprobe an doppelsträngige DNS unter Verwendung von Crithidia luciliae Zellen und Fluoreszentmikroskopie. European patent application EP3971827 (filed 2020).
  2. Menge B, Steinhagen K, Schaefer J, Probst C, Deerberg A, Unger M, Messing C. A novel assay for the diagnosis of nematode infections. Brasilian patent application BR102020012760-8 (filed 2020),
  3. Proost S, Honold L, Pfeiffer T. Set comprising a planar sample carrier having an absorbent membrane layer and having a box (Set mit einem flächigen Probenträger und Schachtel). European, Brasilian and US patent application EP3936233 (filed 2020), BR102021011057 (filed 2021) and US2022/0008912 (filed 2021).
  4. Steinhagen K, Messing C, Lattwein E, Stiba K, Lindhorst F, Neugebauer E, Müller M, Corman V. Methods and reagents for diagnosis of SARS-CoV-2 infection. Korean patent application (filed 2021).
Back to top